SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RDHL

RedHill Biopharma Ltd. (NASDAQ:RDHL)

IL · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
0.42+0.00 (-0.76%)
 
Market cap
$1.32M
Analyst consensus
Listed since
Jan 7, 2013
Insider Score
––Not scored
RDHL Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

RDHL analyst forecast

Best analysts covering RDHL

No firm covering RDHL has enough calls with a finished 1Y holding period to rank yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

RDHL analyst ratings

FirmPrice targetAction
—HC Wainwright & Co.Buy——Reiterated2021-09-15
—Cantor FitzgeraldOverweight——Reiterated2021-08-31
—WBB SecuritiesBuy——Downgraded2021-05-28
—HC Wainwright & Co.Buy——Reiterated2021-05-18
—BTIGBuy——Reiterated2020-09-11
—H.C. WainwrightBuy——Reiterated2020-03-05
—WBB SecuritiesStrong Buy——Upgraded2019-07-12
—WBB SecuritiesBuy——Reiterated2019-03-12
—Ladenburg ThalmannBuy——Reiterated2018-06-25
—NomuraBuy——Reiterated2018-01-26
—Seaport GlobalBuy——Reiterated2017-10-06
—Northland SecuritiesBuy——Reiterated2015-09-29
—Roth CapitalBuy——Reiterated2015-06-16
—H.C. WainwrightBuy——Reiterated2015-03-26

RDHL earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-12-435.000.00$22.7M$0
2026-03-30-435.000.00$22.7M$0
2026-09-30-435.000.00$22.7M$0
2027-03-18-474.290.00$24.5M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.